Pharmacological treatment of Alzheimer's disease Tratamiento farmacológico de la enfermedad de Alzheimer.
Author
dc.contributor.author
Donoso, Amanda
Admission date
dc.date.accessioned
2019-01-29T15:47:36Z
Available date
dc.date.available
2019-01-29T15:47:36Z
Publication date
dc.date.issued
1991
Cita de ítem
dc.identifier.citation
Revista medica de Chile, Volumen 119, Issue 4, 2018, Pages 452-457
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/162415
Abstract
dc.description.abstract
Management of Alzheimer disease includes sedatives, neuroleptic and hypnotic agents for behavior disorders family-directed therapy; activities to maintain functional abilities; care of overall health status and disease specific therapies. The therapeutic attempts specifically based on known or postulated neurophysiological abnormalities are the neurotransmitter replacement therapies (cholinergic enhancement strategies and others); the treatment or prevention of cytoscheletical abnormalities and the neuronal metabolic enhancement with nootropics. There is no definitely useful specific therapy for Alzheimer disease at present. However, increasing research on cholinergic mechanisms, galaninergic interneurons, nerve growth factor and neural grafts, metabolism of amyloid an others, will hopefully lead to useful therapies in the near future.